Jodele, Sonata <br/><br/>
Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation.  [electronic resource] 

 -  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation  Feb 2016 
 - 307-315 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-6536 
<br/><br/><label>Standard No.: </label>10.1016/j.bbmt.2015.10.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Female<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Humans<br/>Male<br/>Metabolic Clearance Rate<br/>Thrombotic Microangiopathies--drug therapy<br/>Transplantation Conditioning--adverse effects